A/S 500m O/S 40m Float 10m. 70m traded so far today. buys > sells. hmmm....
Recent AEON News
- AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711 • GlobeNewswire Inc. • 04/03/2026 08:10:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/03/2026 08:05:14 PM
- AEON Biopharma Receives Additional Notice Related to NYSE American Continued Listing Standards • GlobeNewswire Inc. • 04/03/2026 08:05:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/30/2026 09:36:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/30/2026 09:29:32 PM
- AEON Biopharma Reports Full Year 2025 Financial Results and Highlights Positive Comparative Analytical Results and FDA Feedback for ABP-450 Biosimilar Program • GlobeNewswire Inc. • 03/30/2026 08:05:00 PM
- AEON Biopharma Announces FDA Feedback Following BPD Type 2a Meeting for the ABP-450 Biosimilar Program • GlobeNewswire Inc. • 03/25/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2026 12:13:33 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/09/2026 08:05:20 PM
- AEON Biopharma Appoints John Bencich as Chief Financial Officer • GlobeNewswire Inc. • 03/09/2026 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 11:07:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 11:06:25 PM
- AEON Biopharma Abstract Accepted for Presentation at 2026 American Academy of Neurology (AAN) Annual Meeting • GlobeNewswire Inc. • 03/05/2026 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2026 01:40:27 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/18/2026 09:05:27 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 02/09/2026 09:38:44 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2026 02:25:12 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/21/2026 09:06:10 PM
- AEON Biopharma Reports BPD Type 2a Meeting with FDA and Shareholder Approval of the November Transactions • GlobeNewswire Inc. • 01/21/2026 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2026 02:17:24 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/29/2025 09:05:16 PM
- AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711 • GlobeNewswire Inc. • 12/19/2025 11:00:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 12/19/2025 09:01:12 PM
